Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 8 | Longs Won 7/8 87% | Profit Factor 0.95 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $9,909.57 |
| Average Win $3,032.59 | Best Trade (Mar 21) $13,095.47 | Sharpe Ratio -38.77 |
| Average Loss -$22,406.82 | Worst Trade (Nov 20) -$22,406.82 | Z-Score 6.35 (100%) |
| Commissions $0 | Avg. Trade Length 1m 1w 5d | Expectancy -$88.61 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 1 | 1 | 0 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ELAN Elanco Animal Health Incorporated | 1,271.53 | $30,796.47 | $32,449.45 | - | $1,652.98 | 5.37% | +0.433% |
RPRX Royalty Pharma plc | 566.28 | $31,966.27 | $33,959.56 | - | $1,993.29 | 6.24% | +2.111% |
ZTS Zoetis Inc. | 424.01 | $30,469.51 | $32,882.14 | - | $2,412.63 | 7.92% | +0.819% |